Liberia to receive Zmapp drug to treat Ebola virus


Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola, the Liberian government says.

The move came after a request to the US from Liberian President Ellen Johnson Sirleaf, the government said.

The news came as medical ethics specialists met in Geneva to explore the use of such new treatments.

The World Health Organization, which is hosting the meeting, says some 1,013 have died from Ebola in West Africa.

US government officials said their role had been to put Liberian officials in contact with Zmapp maker Mapp Biopharmaceutical.